UK drug companies must disclose funding of patients' groups
- 12 January 2006
- Vol. 332 (7533) , 69.2-69
- https://doi.org/10.1136/bmj.332.7533.69-a
Abstract
No abstract availableThis publication has 0 references indexed in Scilit:
This publication has 0 references indexed in Scilit: